Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Baldelli

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
NPJ Parkinson'S Disease|September 8, 2021
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patientsLuca Baldelli, Sebastian Schade, Silvia Jesús, et al.
Sleep|October 25, 2021
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study GroupMatteo Cesari, Anna Heidbreder, Erik K St Louis, et al.
Scientific Reports|January 26, 2022
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson's disease patientsElisa Zago, Alessandra Dal Molin, Giovanna Maria Dimitri, et al.
Movement Disorders Clinical Practice|November 21, 2025
Titration Dynamics and Early Treatment Burden in Advanced Parkinson's Disease: A Multicenter Comparison of CSFLI and LCIG Infusion TherapiesBeatrice Pinna, Giuseppe Fenu, Paolo Mellino, et al.
Journal of Parkinson'S Disease|November 4, 2025
Sex differences in clinical and prognostic trajectories in patients with idiopathic REM sleep behavior disorder: Insights from the FARPRESTO cohortMichelangelo Maestri, Michela Figorilli, Federico Meloni, et al.
Brain : a Journal of Neurology|May 29, 2026
Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuumMonica Roascio, Elena Antelmi, Luca Baldelli, et al.
NPJ Parkinson'S Disease|October 17, 2025
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulationFrancesco Bove, Danilo Genovese, Alessandro De Biase, et al.
The Lancet. Neurology|July 24, 2021
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorderMitchell G Miglis, Charles H Adler, Elena Antelmi, et al.
Mechanisms of Ageing and Development|January 1, 2021
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING projectChiara Pirazzini, Tiago Azevedo, Luca Baldelli, et al.
Neurology|October 22, 2025
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a <i>GBA1</i> Pathogenic VariantMicol Avenali, Carlo Alberto Artusi, Roberto Cilia, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
NPJ Parkinson'S Disease|September 8, 2021
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patientsLuca Baldelli, Sebastian Schade, Silvia Jesús, et al.
Sleep|October 25, 2021
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study GroupMatteo Cesari, Anna Heidbreder, Erik K St Louis, et al.
Scientific Reports|January 26, 2022
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson's disease patientsElisa Zago, Alessandra Dal Molin, Giovanna Maria Dimitri, et al.
Movement Disorders Clinical Practice|November 21, 2025
Titration Dynamics and Early Treatment Burden in Advanced Parkinson's Disease: A Multicenter Comparison of CSFLI and LCIG Infusion TherapiesBeatrice Pinna, Giuseppe Fenu, Paolo Mellino, et al.
Journal of Parkinson'S Disease|November 4, 2025
Sex differences in clinical and prognostic trajectories in patients with idiopathic REM sleep behavior disorder: Insights from the FARPRESTO cohortMichelangelo Maestri, Michela Figorilli, Federico Meloni, et al.
Brain : a Journal of Neurology|May 29, 2026
Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuumMonica Roascio, Elena Antelmi, Luca Baldelli, et al.
NPJ Parkinson'S Disease|October 17, 2025
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulationFrancesco Bove, Danilo Genovese, Alessandro De Biase, et al.
The Lancet. Neurology|July 24, 2021
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorderMitchell G Miglis, Charles H Adler, Elena Antelmi, et al.
Mechanisms of Ageing and Development|January 1, 2021
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING projectChiara Pirazzini, Tiago Azevedo, Luca Baldelli, et al.
Neurology|October 22, 2025
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a <i>GBA1</i> Pathogenic VariantMicol Avenali, Carlo Alberto Artusi, Roberto Cilia, et al.
Pageof 6